RxDoctor Payments Data

Darrin Cunningham, DO

Obstetrics & Gynecology · Springdale, ARNPI 1548262306

Payments from drug & device makers

$2,429in general payments, 2019–2025

Across 146 payments — averaging $16.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$944
  • Pfizer$239
  • Exeltis, USA Inc.$173
  • Mayne Pharma Commercial LLC$164
  • Astellas Pharma US Inc$160
  • Johnson & Johnson$157
  • plus $591 from 15 others

What the payments were for

  • Food & beverage$2,24392%
  • Education$1868%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,429 in reported general payments places this provider in the 60th percentile of 272 obstetrics & gynecology providers in Arkansas.

See all obstetrics & gynecology providers in Arkansas

Medicare billing

Part B allowed, 2024
$9,128
Medicare patients
67
Services billed
143

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MyrbetriqMirabegron17$7,239
Estradiol153$4,164
Raloxifene Hcl56$1,981
ProgesteroneProgesterone, Micronized25$970
YuvafemEstradiol11$765
Estradiol (Once Weekly)Estradiol14$709
Medroxyprogesterone Acetate36$220
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst13$128
Levothyroxine Sodium25$89
Clonazepam21$40

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Astellas Pharma US IncMyrbetriq$160$7,23917 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 272 obstetrics & gynecology providers in Arkansas.

Other obstetrics & gynecology in Springdale

See the full list for Arkansas

Where these figures come from

Is this you, or does something look wrong? →